Get the Stockscreener App
2.30
3.36%
-0.08
After Hours:
2.33
0.03
+1.30%
Ventyx Biosciences Inc stock is traded at $2.30, with a volume of 462.11K.
It is down -3.36% in the last 24 hours and down -12.55% over the past month.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
See More
Previous Close:
$2.38
Open:
$2.38
24h Volume:
462.11K
Relative Volume:
0.41
Market Cap:
$164.01M
Revenue:
-
Net Income/Loss:
$-192.96M
P/E Ratio:
-0.697
EPS:
-3.3
Net Cash Flow:
$-167.04M
1W Performance:
-8.73%
1M Performance:
-12.55%
6M Performance:
+57.53%
1Y Performance:
+6.98%
1-Day Range:
$2.30
$2.43
1-Week Range:
$2.30
$2.54
52-Week Range:
$0.783
$3.39
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Name
Ventyx Biosciences Inc
Sector
Industry
Phone
(858) 945-2393
Address
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Compare VTYX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
2.30 | 169.00M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-12-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-07-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-07-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-07-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-07-23 | Downgrade | Stifel | Buy → Hold |
| Nov-07-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-14-23 | Resumed | Credit Suisse | Outperform |
| Mar-21-23 | Initiated | Wells Fargo | Overweight |
| Dec-19-22 | Initiated | Goldman | Buy |
| Nov-17-22 | Initiated | Morgan Stanley | Overweight |
| Sep-07-22 | Initiated | Stifel | Buy |
| Sep-01-22 | Initiated | H.C. Wainwright | Buy |
| May-09-22 | Initiated | Credit Suisse | Outperform |
| Mar-31-22 | Initiated | Canaccord Genuity | Buy |
| Feb-01-22 | Initiated | Oppenheimer | Outperform |
| Nov-15-21 | Initiated | Jefferies | Buy |
| Nov-15-21 | Initiated | Piper Sandler | Overweight |
View All
Ventyx Biosciences Inc Stock (VTYX) Latest News
Will breakout in Ventyx Biosciences Inc. lead to full recoveryJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - Newser
How to track smart money flows in Ventyx Biosciences Inc.Trade Exit Summary & Risk Controlled Stock Alerts - Newser
Does Ventyx Biosciences Inc. show high probability of reboundQuarterly Profit Review & Capital Efficiency Focused Strategies - Newser
Will Ventyx Biosciences Inc. bounce back from current supportJuly 2025 Volume & Fast Gaining Stock Reports - Newser
Does Ventyx Biosciences Inc. qualify in momentum factor screeningJuly 2025 News Drivers & Risk Managed Investment Strategies - Newser
Is Ventyx Biosciences Inc. showing signs of accumulationGap Down & Weekly Watchlist for Hot Stocks - Newser
Ieq Capital LLC Buys New Holdings in Ventyx Biosciences, Inc. $VTYX - MarketBeat
Will Ventyx Biosciences Inc. stock recover after recent dropEarnings Growth Report & Growth Focused Stock Pick Reports - Newser
Chart overlay techniques for tracking Ventyx Biosciences Inc.Weekly Risk Report & Reliable Intraday Trade Alerts - Newser
Is Ventyx Biosciences Inc. stock reversal real or fakeWeekly Investment Report & Weekly Stock Performance Updates - Newser
Multi asset correlation models including Ventyx Biosciences Inc.Bull Run & Free Weekly Watchlist of Top Performers - Newser
Will Ventyx Biosciences Inc. benefit from macro trendsJuly 2025 Intraday Action & High Yield Stock Recommendations - Newser
What Fibonacci levels say about Ventyx Biosciences Inc. rebound2025 Top Gainers & Daily Chart Pattern Signal Reports - Newser
Is now a turning point for Ventyx Biosciences Inc.2025 Biggest Moves & Daily Risk Controlled Trade Plans - Newser
Published on: 2025-09-12 03:58:28 - Newser
Is Ventyx Biosciences Inc. a candidate for recovery playMarket Rally & Daily Stock Trend Watchlist - Newser
What momentum shifts mean for Ventyx Biosciences Inc.2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - Newser
Nuveen LLC Buys Shares of 168,420 Ventyx Biosciences, Inc. $VTYX - MarketBeat
Identifying reversal signals in Ventyx Biosciences Inc.Gold Moves & Capital Efficient Trading Techniques - Newser
Key resistance and support levels for Ventyx Biosciences Inc.Buy Signal & Free Community Supported Trade Ideas - Newser
Technical analysis overview for Ventyx Biosciences Inc. stockJuly 2025 Sector Moves & Safe Entry Point Alerts - Newser
Real time scanner hits for Ventyx Biosciences Inc. explainedWeekly Trade Review & Accurate Intraday Trade Tips - Newser
Volume spikes in Ventyx Biosciences Inc. stock – what they meanMarket Trend Report & Risk Adjusted Buy/Sell Alerts - Newser
Order flow analysis tools used on Ventyx Biosciences Inc.Earnings Overview Summary & Real-Time Chart Pattern Alerts - Newser
Building trade automation scripts for Ventyx Biosciences Inc.2025 Top Gainers & Reliable Volume Spike Trade Alerts - Newser
How institutional ownership impacts Ventyx Biosciences Inc. stock2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Tick level data insight on Ventyx Biosciences Inc. volatilityJuly 2025 Update & Accurate Technical Buy Alerts - Newser
What MACD and RSI say about Ventyx Biosciences Inc.Stock Surge & Risk Adjusted Buy/Sell Alerts - Newser
Ventyx Biosciences Inc. stock outlook for YEARJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
What candlestick patterns are forming on Ventyx Biosciences Inc.July 2025 Technicals & Low Risk Entry Point Guides - Newser
Ventyx Biosciences Inc Stock (VTYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):